Atlas Trials

Catalysis SL

53 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Catalysis SL

RecordFirmDate
Efficacy of Carminal in Helicobacter Pylori Gastritis (NCT07179237)Catalysis SL2025-08-04
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours (NCT06363201)Catalysis SL2024-04-28
Evaluation of DEPREXIL in Patients With Clinical Depression Through Psychological and Neuroendocrine Assessment (NCT06496087)Catalysis SL2022-11-01
Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children (NCT06361992)Catalysis SL2022-03-15
Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome (NCT06437210)Catalysis SL2022-02-15
The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility (NCT05222841)Catalysis SL2021-06-15
Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip (NCT04980534)Catalysis SL2021-01-08
Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 (NCT04407182)Catalysis SL2020-05-04
Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract (NCT04695951)Catalysis SL2019-08-01
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions (NCT03549273)Catalysis SL2019-03-11
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma (NCT03717298)Catalysis SL2018-10-30
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma (NCT03559543)Catalysis SL2018-10-25
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer (NCT03562897)Catalysis SL2018-10-25
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction (NCT03549494)Catalysis SL2018-10-25
Evaluation of Obex® in Overweight and Obesity (NCT03541005)Catalysis SL2018-10-01
Oncoxin® and Quality of Life in Cancer Patients (NCT03550482)Catalysis SL2017-11-01
Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients. (NCT03577535)Catalysis SL2017-11-01
Evaluation of Oncoxin-Viusid® in Prostate Cancer (NCT03543670)Catalysis SL2017-09-16

Track Catalysis SL automatically

Every clearance here is in the API, with alerts when new ones post.